A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease
Apply to Participate
If you are interested in participating in this study, please complete the following preliminary qualification form.
We will follow-up with you after we have received your submission.